Skip to main content
. 2021 Aug 26;20:173. doi: 10.1186/s12933-021-01360-0

Table 2.

Hazard ratios for each of the assessed outcome considering the entire cohort and separately males/females, along with the p for trend among quartiles for each outcome and the relative p for interaction for the sex-based subgroup analysis

MODEL Label Overall Male Female
HRCI ProbChi
Sq
p for trend HRCI ProbChi
Sq
p for trend HRCI ProbChi
Sq
p for trend p for interaction
Primary Composite Outcome vikt_STD_Q2 1.08 (1.03–1.12) 0.0012  < .0001 1.11 (1.05–1.18) 0.0005  < .0001 1.03 (0.97–1.11) 0.3152  < .0001 0.539
vikt_STD_Q3 1.18 (1.13–1.24)  < .0001 1.20 (1.13–1.28)  < .0001 1.16 (1.08–1.24)  < .0001
vikt_STD_Q4 1.45 (1.39–1.52)  < .0001 1.46 (1.37–1.55)  < .0001 1.46 (1.36–1.56)  < .0001
Expanded Composite Outcome vikt_STD_Q2 1.06 (1.02–1.11) 0.0057  < .0001 1.08 (1.02–1.15) 0.0050  < .0001 1.03 (0.97–1.10) 0.3296  < .0001 0.823
vikt_STD_Q3 1.16 (1.11–1.21)  < .0001 1.16 (1.10–1.23)  < .0001 1.15 (1.08–1.23)  < .0001
vikt_STD_Q4 1.41 (1.35–1.47)  < .0001 1.39 (1.31–1.48)  < .0001 1.43 (1.34–1.53)  < .0001
All cause mortality vikt_STD_Q2 1.10 (1.05–1.16) 0.0003  < .0001 1.12 (1.05–1.21) 0.0015  < .0001 1.08 (1.00–1.17) 0.0393  < .0001 0.527
vikt_STD_Q3 1.27 (1.21–1.34)  < .0001 1.31 (1.21–1.41)  < .0001 1.23 (1.14–1.33)  < .0001
vikt_STD_Q4 1.68 (1.59–1.77)  < .0001 1.72 (1.60–1.85)  < .0001 1.63 (1.51–1.76)  < .0001
MI vikt_STD_Q2 0.99 (0.90–1.08) 0.7542 0.06 1.03 (0.92–1.16) 0.5893 0.81 0.91 (0.79–1.06) 0.2412 0.01 0.085
vikt_STD_Q3 1.04 (0.65–1.15) 0.3902 1.04 (0.92–1.18) 0.5205 1.04 (0.89–1.22) 0.5924
vikt_STD_Q4 1.12 (1.02–1.24) 0.0225 1.07 (0.94–1.22) 0.3382 1.23 (1.05–1.44) 0.0109
Stroke vikt_STD_Q2 1.04 (0.95–1.14) 0.3497 0.0002 1.11 (0.98–1.25) 0.0879 0.003 0.97 (0.85–1.11) 0.6472 0.03 0.366
vikt_STD_Q3 1.07 (0.98–1.18) 0.1344 1.09 (0.96–1.23) 0.2022 1.06 (0.93–1.22) 0.3750
vikt_STD_Q4 1.24 (1.13–1.37)  < .0001 1.28 (1.12–1.47) 0.0002 1.20 (1.04–1.38) 0.0151
PCI vikt_STD_Q2 0.97 (0.87–1.07) 0.5287 0.86 0.98 (0.87–1.11) 0.7819 0.69 0.92 (0.76–1.12) 0.4182 0.19 0.447
vikt_STD_Q3 0.97 (0.87–1.08) 0.5657 0.94 (0.81–1.07) 0.3136 1.04 (0.86–1.27) 0.6750
vikt_STD_Q4 1.00 (0.89–1.12) 0.9597 0.94 (0.81–1.08) 0.3517 1.16 (0.95–1.42) 0.1394
CABG vikt_STD_Q2 0.86 (0.72–1.02) 0.0858 0.23 0.84 (0.69–1.03) 0.0939 0.27 0.92 (0.64–1.33) 0.6639 0.90 0.701
vikt_STD_Q3 0.84 (0.70–1.01) 0.0707 0.84 (0.68–1.03) 0.0892 0.86 (0.58–1.29) 0.4640
vikt_STD_Q4 0.90 (0.74–1.09) 0.2915 0.88 (0.71–1.10) 0.2711 0.95 (0.63–1.44) 0.8197
HF vikt_STD_Q2 1.03 (0.95–1.11) 0.4831  < .0001 1.07 (0.96–1.19) 0.2308  < .0001 0.99 (0.89–1.10) 0.8338  < .0001 0.828
vikt_STD_Q3 1.18 (1.09–1.27)  < .0001 1.26 (1.13–1.39)  < .0001 1.09 (0.98–1.22) 0.1262
vikt_STD_Q4 1.43 (1.32–1.55)  < .0001 1.48 (1.32–1.65)  < .0001 1.39 (1.24–1.55)  < .0001
PAD vikt_STD_Q2 1.00 (0.86–1.17) 0.9761  < .0001 1.03 (0.85–1.26) 0.7363 0.002 0.95 (0.75–1.21) 0.6702  < .0001 0.598
vikt_STD_Q3 1.15 (0.98–1.34) 0.0833 1.10 (0.90–1.35) 0.3560 1.20 (0.94–1.53) 0.1342
vikt_STD_Q4 1.55 (1.33–1.81)  < .0001 1.43 (1.17–1.75) 0.0006 1.69 (1.34–2.14)  < .0001
Lower limb revascularization vikt_STD_Q2 0.92 (0.78–1.09) 0.3244 0.001 0.96 (0.77–1.20) 0.7338 0.05 0.87 (0.68–1.12) 0.2895 0.04 0.801
vikt_STD_Q3 1.07 (0.90–1.26) 0.4522 1.13 (0.90–1.41) 0.3087 1.00 (0.77–1.29) 0.9779
vikt_STD_Q4 1.31 (1.10–1.56) 0.0022 1.32 (1.04–1.67) 0.0230 1.30 (1.01–1.67) 0.0447
Foot Ulcer vikt_STD_Q2 1.02 (0.82–1.27) 0.8462  < .0001 1.01 (0.75–1.37) 0.9373 0.05 1.01 (0.73–1.40) 0.9364 0.001 0.239
vikt_STD_Q3 1.30 (1.04–1.61) 0.0194 1.25 (0.93–1.69) 0.1380 1.31 (0.95–1.79) 0.0989
vikt_STD_Q4 1.61 (129–2.00)  < .0001 1.45 (1.07–1.97) 0.0171 1.73 (1.27–2.36) 0.0006